Could a herpesvirus be the cause of Kawasaki disease?

Lancet Infectious Diseases

Volumn 2, Issue 5, 2002, Pages 310-313

  Shingadia, D ^a,b   Bose, A ^a   Booy, R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HERPES VIRUS; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REVIEW; VASCULITIS;

EID: 0036238829     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00265-7     Document Type: Note

References (50)

1. Kawasaki disease
2. Management of Kawasaki disease in the British isles
3. Incidence survey of Kawasaki Disease in 1997 and 1998 in Japan
4. Kawasaki syndrome hospitalisations among children in Hawaii and Connecticut
5. Epidemiology of Kawasaki syndrome in an urban US area with a small Asian population
6. Outbreak of Kawasaki syndrome in Finland
7. Kawasaki syndrome; a review of new epidemiologic and laboratory development
8. Adenoviral diseases in children; a study of 105 hospital cases
9. Adenovirus surveillance on children hospitalised for acute lower respiratory infections in child
10. Kawasaki syndrome cluster in Harris County, Texas and Eastern North Carolina
11. Kawasaki disease: A climate condition?
12. Detection of adenovirus outbreak at a municipal swimming pool by nested PCR amplification
13. Pharyngoconjunctival fever caused by adenovirus type 4: Report of a swimming pool-related outbreak with recovery of virus from pool water
14. Type 3 adenoviral pneumonia occurring in a respiratory, intensive care unit
15. The differentiation of classic Kawasaki disease, atypical Kawasaki disease and acute adenoviral infection
16. Imbalance among T-cell subsets in patients with coronary arterial aneurysm in Kawasaki disease
17. Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cells and CD8+ T cell subsets
18. TCR V beta family repertoire and T cell activation markers in Kawasaki disease
19. Possible polyclonal B cell activation in mucocutaneous lymph node syndrome
20. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome
21. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
22. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease
23. Serial changes of serum interleukin-6, interleukin-8 and tumor necrosis factor alpha among patients with Kawasaki disease
24. Serum interferon concentrations and retroviral serology in Kawasaki syndrome
25. Reduced frequencies of peripheral interferon-gamma producing CD4+ and CD4- cells during acute Kawasaki disease
26. Decreased interferon-gamma producing T cells in patients with acute Kawasaki disease
27. Selective expansion of T cells expressing T-cell receptor variable regions VB2 and VB8 in Kawasaki disease
28. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome
29. Clonal expansion of CD8+ T cells in Kawasaki disease
30. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome
31. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease
32. Circulating surface and cytoplasmic immunoglobulin-expressing B-lymphocytes in Kawasaki disease
33. Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms
34. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms
35. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease
36. Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome
37. Adenovirus infection in patients with Kawasaki disease
38. Animal models of infection-mediated vasculitis: Implications for human disease
39. Murine cytomegalovirus-associated anteritis
40. Interferon-gamma regulated acute and latent murine cytomegalovirus infection and chronic disease of the great vessels
41. Complete sequence and genomic analysis of murine gammaherpesvirus 68
42. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri
43. Murine gammaherpesvirus 68 causes large vessel arteritis in mice lacking interferon-gamma responsiveness: A new model for virus induced vascular disease
44. Non-antigen specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo
45. Kinetic analysis of the specific host response to a murine gammaherpesvirus
46. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role of a viral superantigen
47. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
48. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent for Kawasaki disease
49. Screening for herpesvirus genomes in common acute lymphoblastic leukemia